Cargando…
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review
Viral respiratory infections are risk factors for cardiovascular disease (CVD). Underlying CVD is also associated with an increased risk of complications following viral respiratory infections, including increased morbidity, mortality, and health care utilization. Globally, these phenomena are obser...
Autores principales: | Behrouzi, Bahar, Araujo Campoverde, Maria Viviana, Liang, Kyle, Talbot, H. Keipp, Bogoch, Isaac I., McGeer, Allison, Fröbert, Ole, Loeb, Mark, Vardeny, Orly, Solomon, Scott D., Udell, Jacob A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535809/ https://www.ncbi.nlm.nih.gov/pubmed/33032740 http://dx.doi.org/10.1016/j.jacc.2020.08.028 |
Ejemplares similares
-
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
por: Psotka, Mitchell A., et al.
Publicado: (2020) -
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review
por: Roth, Gregory A., et al.
Publicado: (2022) -
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
por: Bikdeli, Behnood, et al.
Publicado: (2020)